144 related articles for article (PubMed ID: 15610893)
21. Antiproliferative activity of vitamin D compounds in combination with cytostatics.
Pelczynska M; Switalska M; Maciejewska M; Jaroszewicz I; Kutner A; Opolski A
Anticancer Res; 2006; 26(4A):2701-5. PubMed ID: 16886680
[TBL] [Abstract][Full Text] [Related]
22. Curcumin-induced cell cycle arrest and apoptosis in human acute promyelocytic leukemia HL-60 cells via MMP changes and caspase-3 activation.
Tan TW; Tsai HR; Lu HF; Lin HL; Tsou MF; Lin YT; Tsai HY; Chen YF; Chung JG
Anticancer Res; 2006; 26(6B):4361-71. PubMed ID: 17201156
[TBL] [Abstract][Full Text] [Related]
23. Analogs of the hormonal form of vitamin D and their possible use in leukemia.
DeLuca HF; Ostrem VK
Prog Clin Biol Res; 1988; 259():41-55. PubMed ID: 2834744
[TBL] [Abstract][Full Text] [Related]
24. Cisplatin-induced apoptosis in human promyelocytic leukemia cells.
Previati M; Lanzoni I; Corbacella E; Magosso S; Guaran V; Martini A; Capitani S
Int J Mol Med; 2006 Sep; 18(3):511-6. PubMed ID: 16865238
[TBL] [Abstract][Full Text] [Related]
25. Ornithine decarboxylase attenuates leukemic chemotherapy drugs-induced cell apoptosis and arrest in human promyelocytic HL-60 cells.
Hsu PC; Hung HC; Liao YF; Liu CC; Tsay GJ; Liu GY
Leuk Res; 2008 Oct; 32(10):1530-40. PubMed ID: 18339422
[TBL] [Abstract][Full Text] [Related]
26. Combined treatment of leukemia cells with vitamin K2 and 1alpha,25-dihydroxy vitamin D3 enhances monocytic differentiation along with becoming resistant to apoptosis by induction of cytoplasmic p21CIP1.
Iguchi T; Miyazawa K; Asada M; Gotoh A; Mizutani S; Ohyashiki K
Int J Oncol; 2005 Oct; 27(4):893-900. PubMed ID: 16142303
[TBL] [Abstract][Full Text] [Related]
27. Differential activities of 1alpha,25-dihydroxy-16-ene-vitamin D(3) analogs and their 3-epimers on human promyelocytic leukemia (HL-60) cell differentiation and apoptosis.
Nakagawa K; Sowa Y; Kurobe M; Ozono K; Siu-Caldera ML; Reddy GS; Uskokovic MR; Okano T
Steroids; 2001; 66(3-5):327-37. PubMed ID: 11179741
[TBL] [Abstract][Full Text] [Related]
28. Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model.
Wietrzyk J; Nevozhay D; Milczarek M; Filip B; Kutner A
Cancer Chemother Pharmacol; 2008 Oct; 62(5):787-97. PubMed ID: 18188568
[TBL] [Abstract][Full Text] [Related]
29. [Effect of vascular endothelial growth factor on apoptosis and expression of Bcl-2 and Mcl-1 in acute leukemia cells].
Liao XL; Xie XT; Li BS; Li L; Yang LL
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Dec; 8(6):491-5. PubMed ID: 17178043
[TBL] [Abstract][Full Text] [Related]
30. Effect of bleomycin and cisplatin on the expression profile of SRA1, a novel member of pre-mRNA splicing factors, in HL-60 human promyelocytic leukemia cells.
Katsarou ME; Thomadaki H; Katsaros N; Scorilas A
Biol Chem; 2007 Aug; 388(8):773-8. PubMed ID: 17655495
[TBL] [Abstract][Full Text] [Related]
31. Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3.
Lin CC; Kao ST; Chen GW; Ho HC; Chung JG
Anticancer Res; 2006; 26(1A):227-42. PubMed ID: 16475703
[TBL] [Abstract][Full Text] [Related]
32. Glycyrrhizin induces apoptosis in human stomach cancer KATO III and human promyelotic leukemia HL-60 cells.
Hibasami H; Iwase H; Yoshioka K; Takahashi H
Int J Mol Med; 2005 Aug; 16(2):233-6. PubMed ID: 16012754
[TBL] [Abstract][Full Text] [Related]
33. Antioxidants and doxorubicin supplementation to modulate CD14 expression and oxidative stress induced by vitamin D3 and seocalcitol in HL60 cells.
Bondza-Kibangou P; Millot C; El Khoury V; Millot JM
Oncol Rep; 2007 Dec; 18(6):1513-9. PubMed ID: 17982638
[TBL] [Abstract][Full Text] [Related]
34. [Apoptosis resistance and its reversal in harringtonine resistant cell line].
Fang M; Zhang HQ; Xue SB; Pang DB; Chi XS
Yao Xue Xue Bao; 1994; 29(12):891-8. PubMed ID: 7709741
[TBL] [Abstract][Full Text] [Related]
35. A novel indoloquinoline derivative, IQDMA, induces S-phase arrest and apoptosis in promyelocytic leukemia HL-60 cells.
Hu XW; Chien CM; Yang SH; Lin YH; Lu CM; Chen YL; Lin SR
Cell Biol Toxicol; 2006 Nov; 22(6):417-27. PubMed ID: 16906476
[TBL] [Abstract][Full Text] [Related]
36. Chelerythrine and dihydrochelerythrine induce G1 phase arrest and bimodal cell death in human leukemia HL-60 cells.
Vrba J; Dolezel P; Vicar J; Modrianský M; Ulrichová J
Toxicol In Vitro; 2008 Jun; 22(4):1008-17. PubMed ID: 18358694
[TBL] [Abstract][Full Text] [Related]
37. Alterations in protein expression in HL-60 cells during etoposide-induced apoptosis modulated by the caspase inhibitor ZVAD.fmk.
Navakauskiene R; Treigyte G; Savickiene J; Gineitis A; Magnusson KE
Ann N Y Acad Sci; 2004 Dec; 1030():393-402. PubMed ID: 15659822
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of patulin-induced apoptosis in human leukemia cells (HL-60).
Wu TS; Liao YC; Yu FY; Chang CH; Liu BH
Toxicol Lett; 2008 Dec; 183(1-3):105-11. PubMed ID: 18992795
[TBL] [Abstract][Full Text] [Related]
39. Thrombospondin-1 (TSP-1) and TSP-1-derived heparin-binding peptides induce promyelocytic leukemia cell differentiation and apoptosis.
Bruel A; Touhami-Carrier M; Thomaidis A; Legrand C
Anticancer Res; 2005; 25(2A):757-64. PubMed ID: 15868907
[TBL] [Abstract][Full Text] [Related]
40. Biological activity in vitro of side-chain modified analogues of calcitriol.
Opolski A; Wietrzyk J; Siwinska A; Marcinkowska E; Chrobak A; Radzikowski C; Kutner A
Curr Pharm Des; 2000 May; 6(7):755-65. PubMed ID: 10828306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
